Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Waskiewicz

Showing results (101-110 of 120) with videos related to

Pageof 12
Sort By:
Human Molecular Genetics|October 30, 2009
Mutation of the bone morphogenetic protein GDF3 causes ocular and skeletal anomaliesMing Ye, Karyn M Berry-Wynne, Mika Asai-Coakwell, et al.
Human Molecular Genetics|January 12, 2013
Contribution of growth differentiation factor 6-dependent cell survival to early-onset retinal dystrophiesMika Asai-Coakwell, Lindsey March, Xiao Hua Dai, et al.
Human Molecular Genetics|February 25, 2016
A secreted WNT-ligand-binding domain of FZD5 generated by a frameshift mutation causes autosomal dominant colobomaChunqiao Liu, Sonya A Widen, Kathleen A Williamson, et al.
Frontiers in Oncology|August 28, 2020
Predictors of 2-Year Incidence of Patient-Reported Urinary Incontinence After Post-prostatectomy Radiotherapy: Evidence of Dose and Fractionation EffectsAndrea Bresolin, Elisabetta Garibaldi, Adriana Faiella, et al.
Cancers|July 2, 2021
Predictors of Patient-Reported Incontinence at Adjuvant/Salvage Radiotherapy after Prostatectomy: Impact of Time between Surgery and RadiotherapyFernando Munoz, Giuseppe Sanguineti, Andrea Bresolin, et al.
The Journal of Clinical Investigation|September 25, 2014
Mutation of FOXC1 and PITX2 induces cerebral small-vessel diseaseCurtis R French, Sudha Seshadri, Anita L Destefano, et al.
Current Oncology (Toronto, Ont.)|February 23, 2024
Quality of Life Longitudinal Evaluation in Prostate Cancer Patients from Radiotherapy Start to 5 Years after IMRT-IGRTAngelo Maggio, Tiziana Rancati, Marco Gatti, et al.
JAMA Neurology|November 27, 2013
Brain differences in infants at differential genetic risk for late-onset Alzheimer disease: a cross-sectional imaging studyDouglas C Dean, Beth A Jerskey, Kewei Chen, et al.
Acta Oncologica (Stockholm, Sweden)|October 6, 2023
Patient-reported persistent symptoms after radiotherapy and association with quality of life for prostate cancer survivorsSofia Spampinato, Tiziana Rancati, Justyna Magdalena Waskiewicz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 27, 2021
Acute patient-reported intestinal toxicity in whole pelvis IMRT for prostate cancer: Bowel dose-volume effect quantification in a multicentric cohort studyAndrea Bresolin, Adriana Faiella, Elisabetta Garibaldi, et al.
Pageof 12

Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
Human Molecular Genetics|October 30, 2009
Mutation of the bone morphogenetic protein GDF3 causes ocular and skeletal anomaliesMing Ye, Karyn M Berry-Wynne, Mika Asai-Coakwell, et al.
Human Molecular Genetics|January 12, 2013
Contribution of growth differentiation factor 6-dependent cell survival to early-onset retinal dystrophiesMika Asai-Coakwell, Lindsey March, Xiao Hua Dai, et al.
Human Molecular Genetics|February 25, 2016
A secreted WNT-ligand-binding domain of FZD5 generated by a frameshift mutation causes autosomal dominant colobomaChunqiao Liu, Sonya A Widen, Kathleen A Williamson, et al.
Frontiers in Oncology|August 28, 2020
Predictors of 2-Year Incidence of Patient-Reported Urinary Incontinence After Post-prostatectomy Radiotherapy: Evidence of Dose and Fractionation EffectsAndrea Bresolin, Elisabetta Garibaldi, Adriana Faiella, et al.
Cancers|July 2, 2021
Predictors of Patient-Reported Incontinence at Adjuvant/Salvage Radiotherapy after Prostatectomy: Impact of Time between Surgery and RadiotherapyFernando Munoz, Giuseppe Sanguineti, Andrea Bresolin, et al.
The Journal of Clinical Investigation|September 25, 2014
Mutation of FOXC1 and PITX2 induces cerebral small-vessel diseaseCurtis R French, Sudha Seshadri, Anita L Destefano, et al.
Current Oncology (Toronto, Ont.)|February 23, 2024
Quality of Life Longitudinal Evaluation in Prostate Cancer Patients from Radiotherapy Start to 5 Years after IMRT-IGRTAngelo Maggio, Tiziana Rancati, Marco Gatti, et al.
JAMA Neurology|November 27, 2013
Brain differences in infants at differential genetic risk for late-onset Alzheimer disease: a cross-sectional imaging studyDouglas C Dean, Beth A Jerskey, Kewei Chen, et al.
Acta Oncologica (Stockholm, Sweden)|October 6, 2023
Patient-reported persistent symptoms after radiotherapy and association with quality of life for prostate cancer survivorsSofia Spampinato, Tiziana Rancati, Justyna Magdalena Waskiewicz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 27, 2021
Acute patient-reported intestinal toxicity in whole pelvis IMRT for prostate cancer: Bowel dose-volume effect quantification in a multicentric cohort studyAndrea Bresolin, Adriana Faiella, Elisabetta Garibaldi, et al.
Pageof 12